AvroBio Inc (NASDAQ:AVRO)

Stock Price: $1.00

+0.0635 (6.78%)

Updated Mar 31, 2023 08:00 PM GMT+0000

Featured app

Invest now

<p>79% of retail CFD accounts lose money</p>

Overview

Financials

Statistics

Profile

Chart

Market Cap	44.09M
Revenue	0
Gross Profit	0
Shares Out	44.09M
EPS (ttm)
PE Ratio	0.0000
Forward PE	-0.4578
Dividend Rate (ttm)	0.0000
Dividend Yield	0.0000

Trading Day	Mar 31
Last Price	$1.00
Previous Close	$0.94
Change ($)	0.0635
Change (%)	6.78%
Day's Open	0.95
Day's Range	0.9306 - 1
Day's Volume	170.97K
52 Week Range	0.56 - 1.93

Your browser does not support the video tag.

About AvroBio Inc

AVROBIO's vision is to bring personalized gene therapy to the world. The company aims to prevent, halt or reverse disease throughout the body with a single dose of gene therapy designed to drive durable expression of therapeutic protein, even in hard-to-reach tissues and organs including brain, muscle and bone.

Its ex vivo lentiviral gene therapy pipeline includes clinical programs in Fabry disease, Gaucher disease type 1 and cystinosis, as well as preclinical programs in Hunter syndrome, Gaucher disease type 3 and Pompe disease. AVROBIO is powered by its industry leading plato® gene therapy platform, its foundation designed to deliver gene therapy worldwide.

The company is headquartered in Cambridge, Mass., with an office in Toronto, Ontario.

News

AVROBIO down 30% as it reprioritizes pipeline programs January 4, 2022

Quick info

Industry

Biological Product (except Diagnostic) Manufacturing

Sector

Manufacturing

Employees

122

Website

www.avrobio.com

Ticker Symbol

AVRO

Exchange

NASDAQ Stock Exchange

Reporting Currency

USD

AvroBio Inc income statements (2020) (USD)

	June 2020	June 2020	March 2020	March 2020
Total Revenue	N.A	N.A	N.A	N.A
Cost of Revenue	301K	301K	283K	283K
Gross Profit	-301K	-301K	-283K	-283K
Research & Development	20.87M	20.87M	18.27M	18.27M
Selling General & Admin	7.69M	7.69M	8.03M	8.03M
Operating Expense	28.86M	28.86M	26.59M	26.59M
Operating Income	-28.86M	-28.86M	-26.59M	-26.59M
Other Income Expense Net	29K	29K	616K	616K
EBIT	-28.86M	-28.86M	-26.59M	-26.59M
Interest Income	N.A	N.A	N.A	N.A
Pretax Income	-28.83M	-28.83M	-25.97M	-25.97M
Income Tax	N.A	N.A	N.A	N.A
Minority Interest	0	0	0	0
Net Income	-28.83M	-28.83M	-25.97M	-25.97M
Net Income Basic	-28.83M	-28.83M	-25.97M	-25.97M

AvroBio Inc income statements (2019) (USD)

	December 2019	September 2019	June 2019	March 2019
Total Revenue	N.A	N.A	N.A	N.A
Cost of Revenue	245K	215K	200K	190K
Gross Profit	-245K	-215K	-200K	-190K
Research & Development	17.22M	13.04M	12.27M	12.45M
Selling General & Admin	5.97M	4.81M	4.15M	5.06M
Operating Expense	23.43M	18.06M	16.61M	17.70M
Operating Income	-23.43M	-18.06M	-16.61M	-17.7M
Other Income Expense Net	771K	0.92M	557K	597K
EBIT	-23.43M	-18.06M	-16.61M	-17.7M
Interest Income	N.A	N.A	N.A	N.A
Pretax Income	-22.66M	-17.15M	-16.06M	-17.1M
Income Tax	N.A	N.A	N.A	N.A
Minority Interest	0	0	0	0
Net Income	-22.66M	-17.15M	-16.06M	-17.1M
Net Income Basic	-22.66M	-17.15M	-16.06M	-17.1M

AvroBio Inc income statements (2018) (USD)

	December 2018	September 2018	June 2018	March 2018
Total Revenue	N.A	N.A	N.A	N.A
Cost of Revenue	184K	130K	45K	21K
Gross Profit	-184K	-130K	-45K	-21K
Research & Development	12.81M	9.23M	7.41M	5.65M
Selling General & Admin	3.68M	2.87M	2.10M	2.12M
Operating Expense	16.68M	12.23M	9.55M	7.79M
Operating Income	-16.68M	-12.23M	-9.55M	-7.79M
Other Income Expense Net	655K	641K	-0.96M	-454K
EBIT	-16.68M	-12.23M	-9.55M	-7.79M
Interest Income	N.A	N.A	N.A	N.A
Pretax Income	-16.02M	-11.59M	-10.51M	-8.24M
Income Tax	N.A	N.A	N.A	N.A
Minority Interest	0	0	0	0
Net Income	-16.02M	-11.59M	-10.51M	-8.24M
Net Income Basic	-16.02M	-11.59M	-10.51M	-10.49M

AvroBio Inc income statements (2017) (USD)

	September 2017	March 2017
Total Revenue	N.A	N.A
Cost of Revenue	13K	2K
Gross Profit	-13K	-2K
Research & Development	5.41M	1.43M
Selling General & Admin	0.95M	608K
Operating Expense	6.37M	2.04M
Operating Income	-6.37M	-2.04M
Other Income Expense Net	-71K	-33K
EBIT	-6.37M	-2.04M
Interest Income	N.A	N.A
Pretax Income	-6.44M	-2.08M
Income Tax	N.A	N.A
Minority Interest	0	0
Net Income	-6.44M	-2.08M
Net Income Basic	-6.44M	-2.12M

AvroBio Inc balance sheet (2020) (USD)

	June 2020	March 2020	March 2020
Current Cash	244.38M	257.70M	257.70M
Receivables	N.A	N.A	N.A
Inventory	N.A	N.A	N.A
Current Assets	251.02M	265.35M	265.35M
Other Current Assets	4.50M	5.47M	5.47M
Short Term Investments	N.A	N.A	N.A
Long Term Investments	244.60K	254.08K	254.08K
Property/Plant Equipment	3.58M	3.41M	3.41M
Good Will	N.A	N.A	N.A
Intangible Assets	N.A	N.A	N.A
Tangible Assets (Net)	239.79M	256.53M	256.53M
Other Assets	723.40K	719.92K	719.92K
Total Assets	255.57M	269.73M	269.73M
Accounts Payable	2.62M	2.14M	2.14M
Other Current Liabilities	12.79M	10.64M	10.64M
Total Current Liabilities	15.41M	12.77M	12.77M
Total Liabilities	15.78M	13.20M	13.20M
Long Term Debt	N.A	N.A	N.A
Current Long Term Debt	N.A	N.A	N.A
Minority Interest	0	0	0
Common Stock	36.43M	36.01M	36.01M
Treasury Stock	N.A	N.A	N.A
Retained Earnings	-199.51M	-170.68M	-170.68M
Capital Surplus	439.29M	427.20M	427.20M
Shareholder Equity	239.79M	256.53M	256.53M
Other Liabilities	N.A	N.A	N.A

AvroBio Inc balance sheet (2019) (USD)

	December 2019	September 2019	June 2019	March 2019
Current Cash	187.04M	206.36M	90.35M	108.48M
Receivables	N.A	N.A	N.A	N.A
Inventory	N.A	N.A	N.A	N.A
Current Assets	195.70M	213.71M	98.19M	113.68M
Other Current Assets	6.52M	5.23M	6.13M	3.74M
Short Term Investments	N.A	N.A	N.A	N.A
Long Term Investments	492K	492K	N.A	N.A
Property/Plant Equipment	3.70M	2.67M	2.74M	2.86M
Good Will	N.A	N.A	N.A	N.A
Intangible Assets	N.A	N.A	N.A	N.A
Tangible Assets (Net)	186.01M	206.76M	92.63M	106.79M
Other Assets	625K	333K	1.06M	825K
Total Assets	200.51M	217.21M	101.99M	117.37M
Accounts Payable	3.95M	1.41M	2.57M	3.46M
Other Current Liabilities	10.07M	8.50M	6.19M	6.48M
Total Current Liabilities	14.02M	9.91M	8.77M	9.94M
Total Liabilities	14.50M	10.45M	9.36M	10.58M
Long Term Debt	N.A	N.A	N.A	N.A
Current Long Term Debt	N.A	N.A	N.A	N.A
Minority Interest	0	0	0	0
Common Stock	31.64M	31.61M	24.10M	23.95M
Treasury Stock	N.A	N.A	N.A	N.A
Retained Earnings	-144.7M	-122.04M	-104.9M	-88.84M
Capital Surplus	330.71M	328.80M	197.53M	195.63M
Shareholder Equity	186.01M	206.76M	92.63M	106.79M
Other Liabilities	N.A	N.A	N.A	N.A

AvroBio Inc balance sheet (2018) (USD)

	December 2018	September 2018	June 2018	March 2018
Current Cash	126.30M	138.58M	N.A	57.93M
Receivables	N.A	N.A	N.A	N.A
Inventory	N.A	N.A	N.A	N.A
Current Assets	130.02M	140.08M	156.15M	58.48M
Other Current Assets	2.17M	1.50M	1.13M	553K
Short Term Investments	N.A	N.A	N.A	N.A
Long Term Investments	492K	N.A	N.A	N.A
Property/Plant Equipment	2.63M	2.31M	2.05M	604K
Good Will	N.A	N.A	N.A	N.A
Intangible Assets	N.A	N.A	N.A	N.A
Tangible Assets (Net)	122.18M	137.11M	148.32M	53.99M
Other Assets	333K	888K	533K	1.13M
Total Assets	133.48M	143.27M	158.73M	60.22M
Accounts Payable	2.78M	1.58M	4.19M	2.05M
Other Current Liabilities	7.82M	3.85M	5.44M	3.01M
Total Current Liabilities	10.61M	5.43M	9.63M	5.06M
Total Liabilities	11.30M	6.16M	10.41M	6.23M
Long Term Debt	N.A	N.A	N.A	N.A
Current Long Term Debt	N.A	N.A	N.A	N.A
Minority Interest	0	0	0	0
Common Stock	23.81M	23.76M	23.72M	23.94M
Treasury Stock	N.A	N.A	N.A	N.A
Retained Earnings	-71.74M	-55.72M	-44.13M	-33.62M
Capital Surplus	193.92M	192.83M	192.44M	109K
Shareholder Equity	122.18M	137.11M	148.32M	53.99M
Other Liabilities	N.A	N.A	N.A	N.A

AvroBio Inc balance sheet (2017) (USD)

	March 2017
Current Cash	N.A
Receivables	N.A
Inventory	N.A
Current Assets	N.A
Other Current Assets	N.A
Short Term Investments	N.A
Long Term Investments	N.A
Property/Plant Equipment	N.A
Good Will	N.A
Intangible Assets	N.A
Tangible Assets (Net)	N.A
Other Assets	N.A
Total Assets	N.A
Accounts Payable	N.A
Other Current Liabilities	N.A
Total Current Liabilities	N.A
Total Liabilities	N.A
Long Term Debt	N.A
Current Long Term Debt	N.A
Minority Interest	0
Common Stock	23.94M
Treasury Stock	N.A
Retained Earnings	N.A
Capital Surplus	N.A
Shareholder Equity	N.A
Other Liabilities	N.A

AvroBio Inc cash flow (2020) (USD)

	June 2020	March 2020
Net Income	-28.83M	-25.97M
Depreciation	301K	283K
Changes in Receivables	N.A	N.A
Changes in Inventories	N.A	N.A
Cash Change	-13.32M	70.65M
Cash Flow	-21.02M	-22.43M
Capital Expenditures	-488K	-577K
Investments	N.A	N.A
Investing Activity (other)	N.A	N.A
Total Investing Cash Flows	-488K	-577K
Dividends Paid	N.A	N.A
Net Borrowings	N.A	N.A
Other Financing Cash Flows	N.A	N.A
Cash Flow Financing	8.19M	93.66M
Exchange Rate Effect	N.A	N.A

AvroBio Inc cash flow (2019) (USD)

	December 2019	September 2019	June 2019	March 2019
Net Income	-22.66M	-17.15M	-16.06M	-17.1M
Depreciation	245K	215K	200K	190K
Changes in Receivables	N.A	N.A	N.A	N.A
Changes in Inventories	N.A	N.A	N.A	N.A
Cash Change	-19.32M	116.01M	-18.13M	-17.83M
Cash Flow	-18.58M	-13.38M	-17.97M	-17.74M
Capital Expenditures	-766K	-78K	-401K	-340K
Investments	N.A	N.A	N.A	N.A
Investing Activity (other)	N.A	N.A	N.A	N.A
Total Investing Cash Flows	-766K	-78K	-401K	-340K
Dividends Paid	N.A	N.A	N.A	N.A
Net Borrowings	N.A	N.A	N.A	N.A
Other Financing Cash Flows	N.A	N.A	N.A	N.A
Cash Flow Financing	30K	129.47M	238K	252K
Exchange Rate Effect	N.A	N.A	N.A	N.A

AvroBio Inc cash flow (2018) (USD)

	December 2018	September 2018	June 2018	March 2018
Net Income	-16.02M	-11.59M	-10.51M	-8.24M
Depreciation	184K	130K	45K	21K
Changes in Receivables	N.A	N.A	N.A	N.A
Changes in Inventories	N.A	N.A	N.A	N.A
Cash Change	-11.81M	-16.44M	97.09M	51.97M
Cash Flow	-11.43M	-11.99M	-8.25M	-5.98M
Capital Expenditures	-493K	-0.92M	-161K	-263K
Investments	259K	-24K	24K	N.A
Investing Activity (other)	N.A	N.A	N.A	N.A
Total Investing Cash Flows	-234K	-1.2M	-137K	-263K
Dividends Paid	N.A	N.A	N.A	N.A
Net Borrowings	N.A	N.A	N.A	N.A
Other Financing Cash Flows	N.A	N.A	N.A	N.A
Cash Flow Financing	-139K	-3.26M	105.47M	58.21M
Exchange Rate Effect	N.A	N.A	N.A	N.A

AvroBio Inc cash flow (2017) (USD)

	March 2017
Net Income	-2.08M
Depreciation	2K
Changes in Receivables	N.A
Changes in Inventories	N.A
Cash Change	1.42M
Cash Flow	-2.01M
Capital Expenditures	-55K
Investments	N.A
Investing Activity (other)	N.A
Total Investing Cash Flows	-55K
Dividends Paid	N.A
Net Borrowings	N.A
Other Financing Cash Flows	N.A
Cash Flow Financing	3.49M
Exchange Rate Effect	N.A

AvroBio Inc (NASDAQ:AVRO)

About AvroBio Inc

News

Quick info

AvroBio Inc income statements (2020) (USD)

AvroBio Inc income statements (2019) (USD)

AvroBio Inc income statements (2018) (USD)

AvroBio Inc income statements (2017) (USD)

AvroBio Inc balance sheet (2020) (USD)

AvroBio Inc balance sheet (2019) (USD)

AvroBio Inc balance sheet (2018) (USD)

AvroBio Inc balance sheet (2017) (USD)

AvroBio Inc cash flow (2020) (USD)

AvroBio Inc cash flow (2019) (USD)

AvroBio Inc cash flow (2018) (USD)

AvroBio Inc cash flow (2017) (USD)

AvroBio Inc dividends (USD)

Total Valuation

Important Dates

Share Statistics

Valuation Ratios

Stock Price Statistics

Income Statement

About

Key Executives